Literature DB >> 7821896

Nodular hyperplasia surrounding fibrolamellar carcinoma: a zone of arterialized liver parenchyma.

R Saxena1, S Humphreys, R Williams, B Portmann.   

Abstract

We report a case of acetaminophen-induced liver necrosis in a 14-year-old girl. At autopsy, a 9 cm subcapsular nodule was present in the right lobe of the liver which showed distinct zonation: a central greyish white area of fibrolamellar carcinoma with a peripheral fleshy, tan-coloured rim ranging from 1 to 2 cm in thickness. This peripheral zone consisted of nodular, hyperplastic parenchyma resembling the changes seen in focal nodular hyperplasia, and stood out from the adjacent necrotic parenchyma. The sparing of this zone from the deleterious effects of acetaminophen provides indirect evidence of a predominantly arterial rather than portal blood supply to this region. The arterial supply was most probably derived from the tumour vasculature and may explain the parenchymal hyperplasia sometimes reported adjacent to a fibrolamellar carcinoma. Awareness of this phenomenon is essential when evaluating a needle biopsy, as sampling of this region may lead to a false negative diagnosis.

Entities:  

Mesh:

Year:  1994        PMID: 7821896     DOI: 10.1111/j.1365-2559.1994.tb01328.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.

Authors:  A D Pinna; S Iwatsuki; R G Lee; S Todo; J R Madariaga; J W Marsh; A Casavilla; I Dvorchik; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  Indication for treatment and long-term outcome of focal nodular hyperplasia.

Authors:  Glenn K Bonney; Dhanwant Gomez; Ahmed Al-Mukhtar; Giles J Toogood; J Peter A Lodge; Raj Prasad
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

3.  Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis.

Authors:  S-H Zhang; W-M Cong; M-C Wu
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

4.  Hepatocellular carcinoma in a patient with focal nodular hyperplasia.

Authors:  Craig M Coopersmith; Jeffrey A Lowell; Anjum Hassan; Todd K Howard
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

Review 5.  Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives.

Authors:  Prerna Kumar; Ryan M Gill; Andrew Phelps; Asmin Tulpule; Katherine Matthay; Theodore Nicolaides
Journal:  Cureus       Date:  2018-04-24

Review 6.  A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects.

Authors:  Georgios Polychronidis; Anastasia Murtha-Lemekhova; Juri Fuchs; Evdokia Karathanasi; Katrin Hoffmann
Journal:  Onco Targets Ther       Date:  2022-10-03       Impact factor: 4.345

Review 7.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

8.  Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors:  Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  World J Surg Oncol       Date:  2020-05-12       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.